|
(11) | EP 0 704 057 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | NOVEL CLINICAL MARKER AND THERAPEUTIC AGENT IN KIDNEY STONE DISEASE AND METHODS OF USE |